ERBB2 and neoplasm: We performed bulk RNA-Seq on all 62 of these tumor sections and identified 466 DEGs (FDR < 0.1, log-ratio test) that tracked with the median immunofluorescence (IF) HER2/PSA ratio score across the cohort.